Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
Mesenchymal stem cells (MSCs) are the member of multipotency stem cells, which possess the capacity for self-renewal and multi-directional differentiation, and have several characteristics, including multi-lineage differentiation potential and immune regulation, which make them a promising source fo...
Main Authors: | Yueyao Wang, Zhongwen Qi, Zhipeng Yan, Nan Ji, Xiaoya Yang, Dongjie Gao, Leilei Hu, Hao Lv, Junping Zhang, Meng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.742088/full |
Similar Items
-
Update of mesenchymal stem cells in the treatment of Mycobacterium tuberculosis infection
by: Yue LI, et al.
Published: (2022-06-01) -
Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity
by: Carl Randall Harrell, et al.
Published: (2021-11-01) -
Liver mesenchymal stem cells are superior inhibitors of NK cell functions through differences in their secretome compared to other mesenchymal stem cells
by: Furkan Yigitbilek, et al.
Published: (2022-09-01) -
Progress in application of mesenchymal stem cells in treatment of nephropathy
by: YANG Yunzhao, SHI Meihan, ZHOU Cheng, BAI Xueyuan
Published: (2023-01-01) -
On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
by: Anja U. Engela, et al.
Published: (2012-05-01)